Table 2 Clinical outcome for bona fide GCT and GTN patients who received Em-EP. Median follow-up time, 9 months
Clinical outcome | GCT patients, n = 50 (%) | GTN patients, n = 45 (%) |
|---|---|---|
Alive at 4 weeks | 49 (98%) | 44 (98%) |
Alive at 6 months | 46 (92%) | 44 (98%) |
Resistant disease (first relapse) | 19 (38%) | 8 (18%) |
Alive at follow-up | 36 (72%) | 44 (98%) |
Deaths at follow-up | 14 (28%) | 1 (2%) |
Causes of death | • Disease progression (n = 8, 57%) • Sepsis (n = 2, 14%) • Unknown (n = 4, 29%) | • Disease progression (n = 1, 100%) |